Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer.

Tianzhen HeYulian ZhangXueyu LiCaihong LiuGuanqun ZhuXinbao YinZongliang ZhangKai ZhaoZhenlin WangPeng ZhaoKe Wang

Published in: World journal of surgical oncology (2022)

Taken together, this study implied that ANKLE1, EMD, and LEMD2 were promising prognosis predictors and potential immunotherapy targets for PRAD patients.

Keyphrases

prostate cancer
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
poor prognosis
peritoneal dialysis
prognostic factors
radical prostatectomy
risk assessment